vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Primerica, Inc. (PRI). Click either name above to swap in a different company.
Primerica, Inc. is the larger business by last-quarter revenue ($853.7M vs $617.8M, roughly 1.4× Hims & Hers Health, Inc.). Primerica, Inc. runs the higher net margin — 23.1% vs 3.3%, a 19.7% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 11.0%). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 7.2%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
Primerica, Inc. is a multi-level marketing company that provides insurance, investment and financial services to middle-income families in the United States and Canada.
HIMS vs PRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $853.7M |
| Net Profit | $20.6M | $197.0M |
| Gross Margin | 71.9% | — |
| Operating Margin | 1.5% | 28.9% |
| Net Margin | 3.3% | 23.1% |
| Revenue YoY | 28.4% | 11.0% |
| Net Profit YoY | -20.8% | 17.9% |
| EPS (diluted) | $0.08 | $6.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | $853.7M | ||
| Q3 25 | $599.0M | $839.9M | ||
| Q2 25 | $544.8M | $793.3M | ||
| Q1 25 | $586.0M | $804.8M | ||
| Q4 24 | $481.1M | $768.8M | ||
| Q3 24 | $401.6M | $774.1M | ||
| Q2 24 | $315.6M | $803.4M | ||
| Q1 24 | $278.2M | $742.8M |
| Q4 25 | $20.6M | $197.0M | ||
| Q3 25 | $15.8M | $206.8M | ||
| Q2 25 | $42.5M | $178.3M | ||
| Q1 25 | $49.5M | $169.1M | ||
| Q4 24 | $26.0M | $167.1M | ||
| Q3 24 | $75.6M | $164.4M | ||
| Q2 24 | $13.3M | $1.2M | ||
| Q1 24 | $11.1M | $137.9M |
| Q4 25 | 71.9% | — | ||
| Q3 25 | 73.8% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 73.5% | — | ||
| Q4 24 | 76.8% | — | ||
| Q3 24 | 79.2% | — | ||
| Q2 24 | 81.3% | 98.0% | ||
| Q1 24 | 82.4% | 98.2% |
| Q4 25 | 1.5% | 28.9% | ||
| Q3 25 | 2.0% | 32.3% | ||
| Q2 25 | 4.9% | 29.6% | ||
| Q1 25 | 9.9% | 27.5% | ||
| Q4 24 | 3.9% | 64.7% | ||
| Q3 24 | 5.6% | 32.9% | ||
| Q2 24 | 3.5% | 1.0% | ||
| Q1 24 | 3.6% | 24.1% |
| Q4 25 | 3.3% | 23.1% | ||
| Q3 25 | 2.6% | 24.6% | ||
| Q2 25 | 7.8% | 22.5% | ||
| Q1 25 | 8.4% | 21.0% | ||
| Q4 24 | 5.4% | 21.7% | ||
| Q3 24 | 18.8% | 21.2% | ||
| Q2 24 | 4.2% | 0.1% | ||
| Q1 24 | 4.0% | 18.6% |
| Q4 25 | $0.08 | $6.11 | ||
| Q3 25 | $0.06 | $6.35 | ||
| Q2 25 | $0.17 | $5.40 | ||
| Q1 25 | $0.20 | $5.05 | ||
| Q4 24 | $0.10 | $4.92 | ||
| Q3 24 | $0.32 | $4.83 | ||
| Q2 24 | $0.06 | $0.03 | ||
| Q1 24 | $0.05 | $3.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $756.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $2.4B |
| Total Assets | $2.2B | $15.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | $756.2M | ||
| Q3 25 | $345.8M | $644.9M | ||
| Q2 25 | $1.1B | $621.2M | ||
| Q1 25 | $273.7M | $625.1M | ||
| Q4 24 | $220.6M | $687.8M | ||
| Q3 24 | $165.5M | $550.1M | ||
| Q2 24 | $129.3M | $627.3M | ||
| Q1 24 | $105.2M | $593.4M |
| Q4 25 | $540.9M | $2.4B | ||
| Q3 25 | $581.0M | $2.3B | ||
| Q2 25 | $562.7M | $2.3B | ||
| Q1 25 | $549.3M | $2.3B | ||
| Q4 24 | $476.7M | $2.3B | ||
| Q3 24 | $440.1M | $1.9B | ||
| Q2 24 | $362.0M | $2.1B | ||
| Q1 24 | $344.5M | $2.2B |
| Q4 25 | $2.2B | $15.0B | ||
| Q3 25 | $2.2B | $14.8B | ||
| Q2 25 | $1.9B | $14.8B | ||
| Q1 25 | $891.7M | $14.6B | ||
| Q4 24 | $707.5M | $14.6B | ||
| Q3 24 | $602.3M | $14.8B | ||
| Q2 24 | $480.5M | $14.6B | ||
| Q1 24 | $448.1M | $14.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $338.2M |
| Free Cash FlowOCF − Capex | $-2.5M | — |
| FCF MarginFCF / Revenue | -0.4% | — |
| Capex IntensityCapex / Revenue | 10.3% | — |
| Cash ConversionOCF / Net Profit | 2.98× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | $338.2M | ||
| Q3 25 | $148.7M | $202.9M | ||
| Q2 25 | $-19.1M | $162.6M | ||
| Q1 25 | $109.1M | $197.5M | ||
| Q4 24 | $86.4M | $270.6M | ||
| Q3 24 | $85.3M | $207.3M | ||
| Q2 24 | $53.6M | $173.3M | ||
| Q1 24 | $25.8M | $210.9M |
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $79.3M | — | ||
| Q2 25 | $-69.5M | — | ||
| Q1 25 | $50.1M | — | ||
| Q4 24 | $59.5M | — | ||
| Q3 24 | $79.4M | — | ||
| Q2 24 | $47.6M | — | ||
| Q1 24 | $11.8M | — |
| Q4 25 | -0.4% | — | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | -12.8% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 4.3% | — |
| Q4 25 | 10.3% | — | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 5.0% | — |
| Q4 25 | 2.98× | 1.72× | ||
| Q3 25 | 9.43× | 0.98× | ||
| Q2 25 | -0.45× | 0.91× | ||
| Q1 25 | 2.20× | 1.17× | ||
| Q4 24 | 3.32× | 1.62× | ||
| Q3 24 | 1.13× | 1.26× | ||
| Q2 24 | 4.03× | 147.98× | ||
| Q1 24 | 2.32× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
PRI
| Revenues From Sources Other Than Contracts With Customers | $445.9M | 52% |
| Investment And Savings Products Segment Revenues | $340.3M | 40% |
| Other | $56.5M | 7% |
| Segment Revenues From Contracts With Customers | $11.0M | 1% |
